US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

See also:

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. April 24, 2023

    Opioid Judge Rips UnitedHealth's 'Insulting' Coercion Charge

    The top federal judge in multidistrict opioid litigation lashed out Monday against new accusations of using his gavel as a cudgel to bully corporations into settlements, calling the criticism from a major division of UnitedHealth Group Inc. "meritless" and "insulting."

  2. April 11, 2023

    Mich. County, Atty Sanctioned For Opioid Deal Challenge

    A Michigan state judge on Tuesday sanctioned Ottawa County and its outside counsel for filing what she called a frivolous lawsuit challenging a national opioid settlement, ruling the county had an unreasonable interpretation of the deal and that its lawyer lied about who was overseeing the funds.

  3. March 24, 2023

    Opioid Theory Reaches 'Alcohol, Guns, Phones,' 4th Circ. Told

    A West Virginia federal judge's monumental rejection of a multibillion-dollar opioid case correctly avoided a "dramatic rewriting" of state law that would threaten legal exposure for sellers of liquor, cellphones, firearms and other lawful products, drug distributors told the Fourth Circuit on Friday.

  4. March 08, 2023

    Opioid Judge Eyes New Bellwethers Amid 'Unwieldy' Delays

    The Ohio federal judge guiding multidistrict opioid litigation is opening new bellwether frontiers involving pharmacy chains and health insurance entities that have sat on the MDL's sidelines, and he signaled impatience this week with "an inefficient use of judicial resources" amid lengthy settlement talks.

  5. March 01, 2023

    Distributors Win Milestone Trial Over Individual Opioid Abuse

    Pharmaceutical wholesalers aren't responsible for harms to individuals whose family members abused narcotics, a Georgia jury decided Wednesday, capping off a first-of-its-kind trial that threatened to open a massive new front in opioid litigation despite multibillion-dollar settlements covering harms suffered by communities.

  6. February 27, 2023

    Drug Distributors Not The Cause Of Opioid Harm, Jury Told

    Drug distribution companies can't be held responsible for the destruction that opioid addiction wreaked on a Georgia community, attorneys told a Peach State jury during closing arguments Monday, because the availability of the drugs is just one thread in a complex web of potential harm.

  7. February 15, 2023

    'Egregious' Opioid Sales Support $650M Verdict, 6th Circ. Told

    The Ohio counties of Lake and Trumbull late Tuesday defended their milestone $650 million opioid trial win over pharmacy giants CVS, Walgreens and Walmart, telling the Sixth Circuit that their claims that the pharmacies created a public nuisance by "egregious" opioid dispensing aren't barred by federal law.

  8. February 14, 2023

    Opioids More Addictive Than Cocaine, Ga. Jury Told

    Prescription opioids are more addictive than cocaine, a recovering addict told a Georgia jury Tuesday during the third week of a trial against drug distribution giants accused of bombarding a Peach State community with pills for profit.

  9. February 10, 2023

    Opioid Judge Targets 'Unfortunate' Gaps In Pharmacy Deals

    The federal judge overseeing nationwide opioid litigation refused Friday to delay business practice changes at CVS, Walgreens and Walmart locations in two Ohio counties, pressuring the pharmacies to adopt the changes in nationwide settlements and rectify "unfortunate" omissions.

  10. February 06, 2023

    Bank Botched Artist Benton's Trust By $400M, Judge Hears

    Missouri bank UMB "egregiously" mismanaged the collection of prominent 20th-century painter Thomas Hart Benton through four decades of sweetheart sales to executives, art museums and bank customers, and failed to care for and monetize his intellectual property, a judge heard as trial started Monday.